09:02 AM EST, 11/12/2025 (MT Newswires) -- Eledon Pharmaceuticals ( ELDN ) said Wednesday it has priced an underwritten public offering of 15.2 million shares at $1.65 per share and 15.2 million pre-funded warrants at $1.649 per warrant, for expected gross proceeds of about $50 million.

The company said the pre-funded warrants are immediately exercisable at an exercise price of $0.001 per share.

Eledon Pharmaceuticals ( ELDN ) said it also granted underwriters a 30-day option to purchase up to about 4.6 million additional shares.

Proceeds from the offering, expected to close on Nov. 13, will be used to advance clinical development of its pipeline programs and for general corporate purposes, the company said.